Avoiding Antitrust and Competition Pitfalls When Distributing in the U.S. and Europe

Introduction Over the past couple of years as the global economic outlook has become more unsettled, European Union (EU) national member states have been either tightening existing, or introducing new, foreign direct investment (FDI...

Introduction On 12 July 2022, the Competition and Markets Authority (CMA), the U.K.’s principal competition regulator, published the final version of its Interpretative Guidance (Vertical Agreements Guidelines) to accompany the Competition Act 1998 (Vertical...

On 28 February 2023, the U.K. competition regulator, the Competition and Markets Authority (CMA), sought to promote itself as a leading advocate of the ‘Green Agenda’ by publishing for consultation draft guidance on the...

On 18 July 2022, the European Union (EU) Council formally adopted the Digital Markets Act (DMA) which establishes for the first time in the EU an ex-ante system of regulation to address anticompetitive behaviour...

First Prohibition Orders under U.K. NSI Act 2021 Target Acquisition of Technology In July 2022, the U.K. Government used its powers under the National Security and Investment Act 2021 (NSI Act) – which is, in...

In July 2022, the U.K. Government used its powers under the National Security and Investment Act 2021 (NSI Act), the U.K. version of the Committee on Foreign Investment in the United States, to block...

Introduction The U.K. Government’s much-awaited Digital Markets, Competition and Consumer Bill (DMCC Bill) published on 25 April 2023 and sets out far-reaching proposals to establish a new ex ante regulatory regime for digital markets...

In a ruling which could have widespread implications for foreign companies doing business in the U.K., the U.K. competition watchdog, the Competition and Markets Authority ( CMA ), hit Bayerische Motoren Werke AG...

On 10 October 2022, the European Commission commenced formal competition law enforcement proceedings under Article 102 of the Treaty for the Functioning of the European Union (Article 102 TFEU) against global pharmaceutical company Teva...